VSTM
Price
$7.33
Change
+$0.21 (+2.95%)
Updated
Apr 24, 02:54 PM (EDT)
Capitalization
362.49M
ZLDAF
Price
$0.30
Change
+$0.01 (+3.45%)
Updated
Mar 13 closing price
Capitalization
2.67M
Ad is loading...

VSTM vs ZLDAF

Header iconVSTM vs ZLDAF Comparison
Open Charts VSTM vs ZLDAFBanner chart's image
Verastem
Price$7.33
Change+$0.21 (+2.95%)
Volume$301
Capitalization362.49M
Zelira Therapeutics
Price$0.30
Change+$0.01 (+3.45%)
Volume$117
Capitalization2.67M
VSTM vs ZLDAF Comparison Chart
Loading...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VSTM vs. ZLDAF commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VSTM is a Buy and ZLDAF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (VSTM: $7.12 vs. ZLDAF: $0.30)
Brand notoriety: VSTM and ZLDAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VSTM: 128% vs. ZLDAF: 56%
Market capitalization -- VSTM: $362.49M vs. ZLDAF: $2.67M
VSTM [@Biotechnology] is valued at $362.49M. ZLDAF’s [@Biotechnology] market capitalization is $2.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VSTM’s FA Score shows that 0 FA rating(s) are green whileZLDAF’s FA Score has 0 green FA rating(s).

  • VSTM’s FA Score: 0 green, 5 red.
  • ZLDAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both VSTM and ZLDAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VSTM’s TA Score shows that 4 TA indicator(s) are bullish.

  • VSTM’s TA Score: 4 bullish, 6 bearish.

Price Growth

VSTM (@Biotechnology) experienced а +43.55% price change this week, while ZLDAF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VSTM($362M) has a higher market cap than ZLDAF($2.67M). VSTM YTD gains are higher at: 37.718 vs. ZLDAF (-21.723). ZLDAF has higher annual earnings (EBITDA): -3.17M vs. VSTM (-88.92M). VSTM has higher revenues than ZLDAF: VSTM (10M) vs ZLDAF (40.9K).
VSTMZLDAFVSTM / ZLDAF
Capitalization362M2.67M13,538%
EBITDA-88.92M-3.17M2,805%
Gain YTD37.718-21.723-174%
P/E RatioN/AN/A-
Revenue10M40.9K24,450%
Total Cash113MN/A-
Total Debt41.4MN/A-
FUNDAMENTALS RATINGS
VSTM vs ZLDAF: Fundamental Ratings
VSTM
ZLDAF
OUTLOOK RATING
1..100
2434
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3879
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ZLDAF's Valuation (49) in the null industry is somewhat better than the same rating for VSTM (82) in the Biotechnology industry. This means that ZLDAF’s stock grew somewhat faster than VSTM’s over the last 12 months.

ZLDAF's Profit vs Risk Rating (100) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that ZLDAF’s stock grew similarly to VSTM’s over the last 12 months.

VSTM's SMR Rating (97) in the Biotechnology industry is in the same range as ZLDAF (98) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

VSTM's Price Growth Rating (38) in the Biotechnology industry is somewhat better than the same rating for ZLDAF (79) in the null industry. This means that VSTM’s stock grew somewhat faster than ZLDAF’s over the last 12 months.

VSTM's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ZLDAF (100) in the null industry. This means that VSTM’s stock grew similarly to ZLDAF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VSTM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
VSTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ENPSX30.41N/A
N/A
ProFunds UltraSector Energy Svc
JCPRX18.91N/A
N/A
JPMorgan US Large Cap Core Plus R5
PREIX139.10N/A
N/A
T. Rowe Price Equity Index 500
IMOPX3.24N/A
N/A
Voya MidCap Opportunities Port S2
TBDZX16.50N/A
N/A
PGIM Jennison Diversified Growth Z

VSTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, VSTM has been loosely correlated with GNLX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VSTM jumps, then GNLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VSTM
1D Price
Change %
VSTM100%
+1.14%
GNLX - VSTM
47%
Loosely correlated
-1.36%
ZLDAF - VSTM
47%
Loosely correlated
N/A
SNSE - VSTM
45%
Loosely correlated
+6.90%
HOOK - VSTM
39%
Loosely correlated
+4.00%
TGTX - VSTM
38%
Loosely correlated
+3.95%
More

ZLDAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLDAF has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLDAF jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLDAF
1D Price
Change %
ZLDAF100%
N/A
VSTM - ZLDAF
47%
Loosely correlated
+1.14%
QLGN - ZLDAF
28%
Poorly correlated
-0.52%
GNLX - ZLDAF
25%
Poorly correlated
-1.36%
SNSE - ZLDAF
22%
Poorly correlated
+6.90%
KRON - ZLDAF
20%
Poorly correlated
+1.26%
More